7.1900
22-五月-25 13:45:00
15 分钟延时
股票
-0.0800
-1.10%
今日范围
7.1400 - 7.3000
ISIN
N/A
来源
NASDAQ
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
15 5月 2025 05:00:00 条件 Nasdaq GlobeNewswire
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.
08 5月 2025 04:00:00 条件 Nasdaq GlobeNewswire
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
08 2月 2024 13:05:00 条件 Nasdaq GlobeNewswire